Pharmaceuticals
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
Europe, Israel, and the medical record of a nation - opinion
How Evogene is changing the future for the pharma and agriculture markets
Taking too many medications may harm older adults, study warns
Israel's Health, Finance ministries to freeze rise in medication prices
In order to freeze the price increase, Israeli law requires the approval of the finance and health ministers, as well as the ratification of the Health Committee.
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute
Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.
Israeli customer attacks pharmacists because of long wait in queue
After the attack by an impatient customer, the pharmacist was slightly injured and was taken to Ichilov Hospital in Tel Aviv.
Nefesh B’Nefesh to hold ‘MedEx’ event to streamline Aliyah logistics for medical professionals
Nefesh B’Nefesh MedEx event will enable medical professionals to take major steps towards transferring their medical licenses before making Aliyah - in person and in one location.
Israeli drugmaker Teva says opioids settlement to move forward in US
As a result of the opiod crisis, more than 932,000 people have died in the US since 1999 from a drug overdose.
A new joint working group established by the Israel-America Chamber of Commerce
After Biden's declaration and U.S. objectives: Israel-America Chamber of Commerce established a joint working group for industry and patient-oriented organizations to eradicate cancer.
Israel facing severe medication shortage - pharmacists
The Israeli Pharmacists Association claimed that the medication shortage is not being managed properly by government bodies, the Health Ministry in particular.
Teva to pay $523m. to New York as it looks to move past opioid lawsuits
Teva Pharmaceutical Industries will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the US opioid epidemic.
Getting over the counter drugs in Israel? Wolt expands services
Wolt announced that it has partnered with Be Pharma in order to offer non-prescription drugs with immediate delivery in under an hour.
Super-Pharm purchases eyewear chain Erroca in $23m deal
Erroca has an annual sales turnover of approximately NIS 100 million through its 60 branches.
